ArticleESMO gastrointestinal oncology2026
Real-world outcomes and prognostic factors of trifluridine/tipiracil plus bevacizumab in metastatic colorectal cancer: a multicenter study in Spain.
N Martínez-Lago et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.